Articles

Myeloid leukaemia in cats: a malignant blood disease

Myeloid leukaemia is a malignant disease of the blood-forming system in which the bone marrow's myeloid cell line grows abnormally. Uncontrolled division of immature cells displaces normal blood production, causing severe anaemia, impaired immunity and a tendency to bleed. It is less common than lymphoma or lymphoid leukaemia and is often associated with feline leukaemia virus, FeLV.

7 min readSources

When to see a vet urgently

Disrupted bone marrow function can quickly become serious. Seek urgent assessment if your cat has:

  • very pale gums, severe weakness or collapse;
  • difficulty breathing or clearly rapid breathing even at rest;
  • persistent bleeding or new widespread bruising;
  • fever and rapidly deteriorating condition, particularly with low neutrophils or during chemotherapy.

Do not wait for every symptom to appear. You can find a vet near you.

Overview

Myeloid leukaemia belongs to the myeloproliferative disorders. Its course may be acute, with rapid progression and predominantly blast cells, or chronic, developing slowly with increased numbers of mature cells. The acute form is more often diagnosed in cats and has a poor prognosis.

The myeloid lineage includes more than one white blood cell type. It also encompasses red blood cell precursors, precursors of platelet-producing cells and several white cell lines. Diagnostic names may therefore refer to myeloblastic, monocytic or erythroid leukaemia, for example. Identifying the subtype requires examination of cell characteristics.

Acute and chronic leukaemias are not simply different-duration stages of one disease. In chronic disease, cells are generally more mature and health may remain stable longer. In acute disease, normal blood production may already be severely disrupted when symptoms are first noticed. Acute therefore does not identify the day the cellular change began.

Causes

  • FeLV infection: the main risk factor directly associated with leukaemia development.
  • Hereditary susceptibility.
  • Immunodeficiency, for example FIV.
  • Exposure to carcinogens and toxins.
  • Spontaneous mutations in bone marrow cells.

FeLV has a recognised association with feline myeloid cancers, but disease can also develop without detectable FeLV infection. Research into the precise contribution of the other listed factors specifically to feline myeloid leukaemia is limited. An individual case usually cannot be attributed to a particular household exposure or proven inherited cause.

Leukaemia and FeLV infection are different diagnoses. The virus can cause anaemia, immune dysfunction or other marrow changes without malignant leukaemia. Equally, a negative viral test alone does not rule out leukaemia. Cancer is identified by examining blood cells and, when needed, bone marrow cells.

Risk factors

  • FeLV-positive cats.
  • Cats in rescue shelters and breeding establishments, with greater viral transmission risk.
  • Young and adult cats, most often aged 2–6 years.

This age range is not required for diagnosis: disease has also been described in elderly cats. Living in a shelter or breeding establishment does not itself establish cancer. Infection risk depends on the cats' actual FeLV status and contacts. Neither background nor age can determine the diagnosis.

Typical symptoms

  • Progressive weakness and apathy.
  • Pale mucous membranes from anaemia.
  • Recurrent infections from low white blood cells and impaired immunity.
  • Gum bleeding, pinpoint haemorrhages or nosebleeds from low platelets.
  • An enlarged spleen and liver.
  • Weight loss and reduced appetite.
  • Gradual wasting in chronic disease or rapid collapse in acute disease.

These signs are not specific to leukaemia. Bleeding, red blood cell destruction and other blood-production disorders can cause similar weakness and paleness. Fever and weight loss also have several causes. The vet assesses whether findings relate to one marrow disease or other problems need investigation.

The total white blood cell count can be high even when too few effective defence cells are present. Numerous abnormal cells do not guarantee normal immunity. Conversely, few blast cells may enter circulation despite substantial marrow disease. A high or low white cell count alone therefore cannot identify it.

Complications and consequences

  • Severe anaemia and oxygen deprivation.
  • Sepsis and secondary infections.
  • Heavy bleeding.
  • Multiple organ damage.
  • Death.

Diagnosis at the vet

  • A complete blood count to detect blast cells, anaemia and low platelets.
  • A blood smear and cytological examination.
  • Bone marrow sampling, the main confirmatory method.
  • FeLV and FIV tests.
  • Abdominal ultrasound to assess liver and spleen enlargement.
  • Chest X-rays to assess enlarged lymph nodes.

Why do the cells need examination too?

An automated blood count is an important starting point, but abnormal precursors may be assigned to the wrong cell group. A smear assesses appearance and maturity alongside changes in other blood cells. Reticulocyte testing helps show whether marrow is responding to anaemia by producing new red cells. Simultaneous reductions in several cell lines strengthen the need to investigate marrow function.

A marrow sample can assess blast proportion, maturation and the state of other cell lines. Special stains or cellular marker tests may be used when needed. These distinguish myeloid leukaemia from lymphoid leukaemia or lymphoma involving the marrow, for example. Suitable feline markers are limited, so one test cannot always classify the disease. Myelodysplasia and other marrow disorders can also resemble leukaemia.

Abnormal cell maturation alone nevertheless does not confirm acute leukaemia. Other illnesses or certain medicines can produce similar changes, which must be considered when interpreting the sample.

Ultrasound and X-rays help assess organ changes and concurrent illness, but normal imaging does not rule out marrow cancer. An unclear FeLV result or one poorly matching the cat's background may need confirmation by another method or repeat sampling. Viral results and cancer classification are assessed separately.

Treatment and prognosis

Supportive care and possible cancer treatment

Severe anaemia may require a blood transfusion. This can relieve weakness from poor oxygen transport but does not remove the abnormal marrow cells. Infections, bleeding, dehydration and inadequate nutrition are treated according to the patient's condition. Necessary support can begin while diagnosis is refined if the cat is unwell.

Chemotherapy may be considered with a vet experienced in oncology. However, there are few treatment studies of feline acute myeloid leukaemia, and some knowledge comes from individual case reports. No single reliably effective protocol can be promised. Human leukaemia outcomes or good responses in other feline cancers should not be transferred directly to this disease.

Agree treatment goals before starting. They may include symptom relief, improved blood values and the best possible quality of life. Visible improvement does not always mean marrow function has recovered or cancer is controlled. Response is therefore assessed through condition and repeated laboratory tests.

Monitoring and quality of life

Chemotherapy can also reduce normal blood cells, making check-ups particularly important when marrow is already diseased. The vet sets sampling dates and gives instructions for fever, loss of appetite or bleeding. At home, record eating, energy, breathing and new bleeding signs. Sudden changes require contact even when the next appointment is already booked.

Acute disease generally has a poor prognosis, but decisions are not based on the name alone. Anaemia and bleeding severity, infections, response and the burden on the cat all matter. Palliative care can be a reasonable choice without chemotherapy too. It focuses on relieving suffering and supporting daily life, with treatment limits agreed with you.

Prevention

  • The main protection against FeLV-associated risk is a vaccine against feline leukaemia virus. Your vet plans primary vaccination and boosters according to the product, age, local infection situation and lifestyle, including outdoor access or contact with other cats. Testing is performed before vaccination.
  • Avoid contact with infected cats.
  • Test for FeLV before mating and in breeding establishments.
  • Support immunity through balanced nutrition and good care.

FeLV recommendations also consider regional infection patterns: recommendations for all young cats particularly concern areas where the virus is common. Individual exposure risk and product instructions determine the plan. Vaccination reduces FeLV-associated risks but is not general protection against every myeloid leukaemia and does not treat an existing cancer.

Important for cat owners

Myeloid leukaemia is a severe cancer most often associated with FeLV. Remember that FeLV prevention and regular testing are central to reducing risk. Anaemia signs, bleeding or prolonged weakness require urgent veterinary assessment. Despite the poor prognosis, early identification helps improve quality of life and prolong survival through supportive care.

This article provides general information and does not replace veterinary care. If you notice signs of illness in your cat, contact a vet.

Frequently asked questions

Does a positive FeLV test mean myeloid leukaemia?

No. The test assesses viral infection, whereas cell examination identifies leukaemia. FeLV can cause several diseases and symptom-free infection. An abnormal blood count needs its own investigation regardless of viral results.

Is leukaemia possible without a high white blood cell count?

Yes. Disease may predominantly affect marrow, without many circulating blast cells. The vet assesses red cells, platelets, white cell types and appearance together. Investigation continues with marrow sampling when necessary.

Does improvement after a transfusion mean recovery?

Not necessarily. A transfusion supports oxygen transport and can relieve anaemia symptoms, but cancer cells may continue disrupting blood production. Follow-up assesses whether benefit persists and marrow begins producing enough normal blood cells.

This article is for general information only and is not a guide to treatment. If you notice the first signs of illness, contact your vet.

Paw4care editorial team

Sources

Tools
Cat symptom checkerVaccination scheduleIs it poisonous?Breed finderWhich breed suits you?Food calculatorAge in human yearsAll tools →